Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Recruiting

Phase 2

Indoximod with ChemotherapyPediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Sponsor:

Theodore S. Johnson

Code:

NCT04049669

Conditions

Glioblastoma

Medulloblastoma

Ependymoma

Diffuse Intrinsic Pontine Glioma

Eligibility Criteria

Sex: All

Age: 3 - 21

Healthy Volunteers: Not accepted

Interventions

Indoximod

Partial Radiation

Full-dose Radiation

Temozolomide

Cyclophosphamide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-03. This information was provided to ClinicalTrials.gov by Theodore S. Johnson on 2025-07-16.